By Holly Alyssa MacCormick A single infusion of a modified CAR-T cell therapy could pave the way for a potential one-shot cure for HIV, according to preliminary findings of a small, early-stage clinical trial. Steven G. Deeks, MD, the principal investigator of this California Institute for Regenerative Medicine (CIRM)-funded clinical trial, discussed the findings at a recent CIRM board meeting. Steven Deeks, MD Photo: UCSF Roughly 40 million people worldwide and more … Continue reading Early trial shows promise for one‑shot cure for HIV
Dr. Steven Deeks
Pioneering a new approach to HIV and AIDS
Dr. Steven Deeks. Photo courtesy UCSF I’ve always been impressed by people's willingness to step forward and volunteer for a clinical trial. Even more so when they are the first person ever to test a first-in-human therapy. They really are pioneers in helping advance a whole new approach to treating disease. That’s certainly the case … Continue reading Pioneering a new approach to HIV and AIDS
CIRM Board Approves Four New Clinical Trials
A breakdown of CIRM's clinical trials by disease area This past Thursday, the CIRM Board approved four new clinical trials and ten new discovery awards. These awards bring the total number of CIRM‑funded clinical trials to 68 and allow the agency to surpass its strategic goal of launching 50 new trials. CIRM awarded $8,970,732 to … Continue reading CIRM Board Approves Four New Clinical Trials